Premium
Weekly paclitaxel plus cetuximab reduces the lung metastasis of adenoid cystic carcinoma arising from the salivary gland
Author(s) -
Yoshioka Yukio,
Toratani Shigeaki,
Nakatao Hirotaka,
Koizumi Kouichi,
Hayashido Yasutaka,
Okamoto Tetsuji
Publication year - 2015
Publication title -
oral science international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.256
H-Index - 13
eISSN - 1881-4204
pISSN - 1348-8643
DOI - 10.1016/s1348-8643(15)00019-1
Subject(s) - adenoid cystic carcinoma , salivary gland , medicine , cetuximab , paclitaxel , lung , oncology , chemotherapy , regimen , salivary gland cancer , metastasis , pathology , carcinoma , cancer , colorectal cancer
Adenoid cystic carcinoma (ACC) of the salivary gland often metastasizes to the lungs. It has previously been reported that the combination chemotherapy of weekly paclitaxel plus cetuximab is effective for the treatment of lung metastasis from ACC of the salivary gland. Here, we report a case in which a regimen of this combination therapy provided an antitumor treatment for lung metastatic ACC arising from the minor salivary gland of the hard palate.